INTRODUCTION
Gallbladder cancer (GBC) is a rare biliary tract malignancy in most western countries, but is much widespread in some other regions of the world. Moreover, this carcinoma is infrequent in developed countries but more common in some developing countries, characterized by its lack of symptoms at initial stage leading to difficulties in treatment.
The extensive variation in geography, ethnicity, and cultural differences in the incidence of gallbladder cancer suggests the role of key genetic and environ mental factors associated with the development and progression of the disease [1, 2] . The lack of a serosal layer of gallbladder adjacent to the liver thus enabling hepatic invasion and metastatic progression is one of the major cause of its miserable prognosis [3] . The present review provides a recent update of studies regarding epidemiology, pathogenesis and molecular genetics of gallbladder cancer as available in literature.
EPIDIMIOLOGY OF GALLLBLADDER CANCER
Gallbladder cancer shows an unusual geographic distribution worldwide with substantial geographic variation. Data from Mapuche Indians from Valdivia, Chile, South America shows the rate of gallbladder cancer as: 12.3/100000 for males and 27.3/100000 for females [3] . The native people is these countries exceed for gallbladder cancer mortality rates from cervical (8.0/100000), breast (8.7/100000), pancreatic (7.4/100000), and ovarian cancers (7.3/100000) [3] . American Indians in New Mexico, USA, have also very high average annual rate of GBC (8.9/100000) [ Although the worldwide occurrence of gallbladder cancer is less than 2/100000 individuals, but this has been recorded with extensive variance [5] . The residents of IndoGangetic belt particularly females of northern India (21.5/100000) and south Karachi Pakistan (13.8/100000) have been reported as one of the highest affected regions [4] . Gallbladder cancer is also found in high frequency in Eastern Europe include Poland (14/100000 in Poland), Czech Republic, and Slovakia and Asia whereas south Americans of Indian descent (3.7 to 9.1 per 100000), Israel (5/100000) and Japan (7/100000) have shown intermediate prevalence of gallbladder cancer [4, 6] . The residents of Andeanarea, North American Indians and Mexican Americans are specially predisposed of GBC [6] . The majority of the world has decreasing mortality trends in gallbladder cancer but GBC frequency is constantly rising in Shanghai, China which is substantial cause of mortality [7] . Although Gallbladder cancer is more common in females still in some countries like Korea, Iceland and Costa Rica, higher mortality rate has been reported for males as compare to females [8] . The data from National Cancer Institute; SEER Program (http:// seer.cancer.gov/) has revealed only little turn down in incidence over the past few decades.
ETIOLOGICAL FACTORS FOR GBC

PATHOGENESIS
The development of gallbladder cancer has been linked to various genetic and environmental factors. Chronic infection of gallbladder or/and environmental exposure to specific chemicals, heavy metals, and even many dietary factors, have been found to be associated with GBC formation. The dramatic association of GBC with female gender and certain geographical regions (mostly developing countries) has been proposed to be influenced by various female hormones, cholesterol cycling and salmonella infections in existing literature [9, 10] . Worldwide GBC affects females 23 times more commonly than males, but bias varies greatly in different parts of the world mostly in high prevalent regions of GBC [4, 6] . To some extent, the female hormone estrogen causes increased cholesterol super saturation in bile and hence involved in gallstone mediated GBC pathogenesis [11] . Although the female gender GBC can be linked with the role of female hormones. However an article published previously has questioned the association of hormone receptor expression to tumor differentiation [12] . So the extent of female hormones contribution in Gallbladder cancer is still not certain and requires more investigation.
Other wellknown GBC associated risk factors such as porcelain gallbladder, Mirizzi's syndrome and bile reflux has also been playing a major role as a predisposing factors of this disease [9] . Family history of gallstones, tobacco consumption, chemical exposure, residence in Gangetic belt and high concentrations of secondary bile acids, excessive intake of fried foods (reused oil), increases the risk for GBC [13] . Present data suggest that gallstones are a major risk factor for GBC but their role as a cause for gallbladder cancer is still not certain. A review article by Shrikhande et al [14] has also supported the fact that the populations reporting high incidence of gallbladder cancer with associated gallstones, prophylactic cholecystectomy should be done only after correlating with the epidemiological profile of the place. Convincing evidence also exists for the presence of gallstones as strongly associated factor for gallbladder cancer etiology [7] . Most of the etiological factors are summarized in Table 1 [6,7, 10, 13, 1550] .
Familial and linkage studies
Swedish familycancer database and Utah cancer registry has reported the first ever data for familial clustering of GBC [51] . This study has provided the first data on familial clustering of gallbladder cancer based on medically confirmed records, in which it was estimated that 26% of gallbladder cancers are familial. The significant risk in 3 rd degree relatives and the disease manifestation in several high risk pedigrees as reported in previous studies gives a strong indication for genetic susceptibility to GBC [51] . The high risk heritable factors are likely to contribute to a large extent to this cancer further modulated by environmental factors. The nationwide Swedish Family Cancer Data base from the Swedish Cancer Registry (10.2 million individuals from the year 19611998), has reported maternal transmission favoring over paternal in familial gallbladder cancers [52] . Furthermore, the clustering of gallbladder cancer within families is suggestive of a critical role of genetics in its development [19] . Carcinoma gallbladder was detected in two siblings from Brazil as reported by Trajber et al [53] . Role of allele specific mutations in pathogenesis of carcinoma gallbladder has also been reported [54] .
Another report by Pandey et al [55] has shown higher frequency of carcinoma gallbladder in patients with A+ and AB+ blood groups to which the reason is still unknown.
GENETIC AND MOLECULAR ALTERATION
REPORTED IN GALLBLADDER
CARCINOMA
The present existing information regarding genetic and molecular alterations in GBC is still very much limited. Like other neoplasms, GBC is a multifactorial disorder involving multiple genetic alterations [5658] . Abnormality in tumor suppressor genes, oncogenes, and DNA repair genes, presence of microsatellite instability (MSI) and epigenetic alterations mainly caused by aberrant promoter methylation of gene areas are some of the various well known factors reported till now. The serious of genetic alteration leading to gallbladder cancer formation is still not established clearly. Some of the molecular alterations reported so far are enumerated in Tables 24.
GENETIC ALTERATIONS IN GBC
KRAS
KRAS act as initial key player in numerous signal transduction mechanisms and associated pathways. Many pathogenic mutations have been reported in KRAS oncogene in Gallbladder cancer tissue [5863] .
KRAS gene mutations identified in GBC mostly affects codons 12, 13 and 61. In north India KRAS codon 13 mutation is more common (about one third) than codon 12 and 61 [64] . However many other studies have not detected any mutations in this gene [65, 66] . Tobacco consumption [15] Sex [6] , BMI [16] Mustard oil [17] Argemone oil (AO) and butter yellow (BY) [18] Family history [7, 19] Early age at first pregnancy [20] Cholelithiasis [6, [22] [23] [24] Use of Oral contraceptives [15, 25, 26] Chronic cholecystitis, porcelain gallbladder [27, 28] Red Chili pepper [29, 30] Chronic infection by Salmonella species, S. paratyphi or S. typhican [6, 10, [31] [32] [33] [34] Occupational exposure, Benzene [17, 35] Helocobacter pylori [36, 37] Secondary bile acids [13, [38] [39] [40] High parity [20, 21, 24, 26] Xanthogranulomatous cholecystitis [41] Anomalous pancreatobiliary duct junction [42, 43] Heavy metals [44, 45] Porcelain gallbladder [46] Genetic factors [48] Gallbladder polyp [47] Obesity [49] Free radical oxidation products [50] deregulated survival of genetically impaired abnormal cells which can lead to neoplastic conversion of later on [70] . TP53 mutations are relatively more common in later stages of the disease [63, 66, 7173] . Most of the TP53 mutations associated with GBC are missense mutations that produce a nonfunctional protein with an in creased halflife. The existing literature has reported mutations of the TP53 gene in between approximately 27% to 70% of gallbladder carcinomas [74] . Many codons of the TP53 codons are affected by pathogenic to normal condition [65, 67, 68] . However mutation of KRAS gene has never been detected in GBC having adenoma carcinoma sequence of development [69] (Table 2) .
TP53
TP53 is a wellknown tumor suppressor gene and has various mechanisms of anticancer function and plays significant role in maintenance of genome integrity, apoptosis, genomic stability, and inhibition of angiogenesis etc. Loss of TP53 function allows [75] . Details are shown in various existing literature is shown in Table 2 [ 54, 60, 63, 64, 7686] .
C-ERB-B2
The oncogene c-erb-B2 is a homologue for epidermal growth receptor, encoding a protein with tyrosine kinase activity. The immunohistochemical expression of cerbB2 has been found positive between 10%46% of gallbladder cases. However its expression has been found to be absent in dysplasia or adenomas as shown by previous reports [87, 88] . Animal model studies in transgenic mice have shown that erbB2 overexpression in the basal layer of the biliary tract epithelium led to the development of GBC in all (100%) of mice. Moreover, the expression of HER2⁄neu was positively observed in 28% of GBCs which was directly correlated with advanced stage of cancer [89] . Therefore, it can be hypothesized that some oncogene is associated with in Gallbladder cancer progression. In a study from India, CerbB2 was frequently expressed in well differentiated and stage Ⅱ to stage Ⅳ in about 9.4% of GBC cases [90] . A recent report showed HER2/ neu overexpression occurred in 14% of the advanced gallbladder cancer cases, and this subgroup was expected to be benefited from HER2/neu pathway inhibitors [91] .
Therapeutic targeting of EGFR/HER2
pathways boosts the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas as shown by a previous study [92] . Based on facts it can be concluded that C-ERB-B2 expression can become a marker for a poor prognosis.
HIGH THROUGHPUT MUTATION STUDIES IN GBC
High throughput research has made large scale repetition of experiments feasible as it automates the experiments thus it has now become possible to study how all 21000 genes potentially contribute to cell function or disease. But in case of gallbladder cancer there are very limited high throughput studies. One of the pioneer studies published in nature genetics using high throughput approach by Chinese population has found recurrent mutations in ErbB pathway [93] . Javle et al [94] has found 26 missense mutations with more common TP53 and PIK3CA mutations in GBC tumor using NGS technology. Mutation profiling of gallbladder cancer tissue in Indian population has found PIK3CA and KRAS mutations as most common among this ethnicity [95] . The variability in the results is an indicator of intratumoral heterogeneity of cancer, which describes the observation of different tumor cells showing distinct morphological and molecular profiles including variable gene expression but ultimately leading to a common phenotype. The high throughput mutation studies in GBC are presented in Table 3 [9396]
.
GENE EXPRESSION STUDIES IN GBC
In order to identify potential biomarkers for GBC progression, many studies have been performed to find out the differential gene expression profiles between normal and tumor cells. Existing data various greatly, despite of same grade and stage of the included study subjects. Table 4 [97101] and Table   5 [ 54, 66, 75, 84, 86, 90, 102180] are summarizing global and single gene expression studies reported in GBC respectively.
LOSS OF HETEROZYGOSITY AND MICROSATALLIE INSTABILITY
Loss of heterozygosity (LOH) is a common genetic alteration in cancer genome. The events like he terozygous deletion of one of the two alleles, or duplication of a maternal or paternal chromosome or chromosomal region and concurrent loss of the other allele gives rise to LOH. The studies focused to detect loss of heterozygosity (LOH) in GBCs have shown frequent heterozygous allelic loss which spans in 18 different chromosomal regions [57] . Cytogenetic locations involved in frequent loss of heterozygosity i.e., 3p, 8p, 9p, and 22q regions have also been identified in GBC from different populations; which have also been reported in several other cancers like Retinoblastoma, melanoma, Squamous cell carcinoma of larynx [181183] .
In particular, gallbladder tumor shows numerous site of allelic loss in the short arm of chromosome 3, which harbors several known or putative tumor suppressor genes [109, 181] . High degree of microsatellite instability (MSI) in 10% of GBC cases was observed as reported in research article published by Goldin et al [184] . A different pattern of allelic loss has also been detected in Japanese population. In this report the allelotype analysis of gallbladder carcinoma revealed an interesting asso ciated with anomalous junction of pancreaticobiliary duct [68] . 
METHYLATION AND GALLBLADDER CANCER
Understanding of DNA methylation patterns of gallbladder tumors can prove to be important biomarkers to refine the diagnosis and prognostic information which ultimately helps in appropriate therapeutic selection. Hypermethylation in gene promoter regions is a common epigenetic mechanism for the inactivation of tumor suppressor genes. One of the important research article published previously has found an important link between methylation and survival. In this study methylation of genes p73, MGMT, and DCL1 was significantly associated with Overexpression (9.4%) India [90] survival of gallbladder cancer patients [194, 195] . The study was conducted in a series of 109 advanced gallbladder cancer cases. However genes like CDH13 and FHIT did not show any significant tendency with respect to gallbladder cancer patient's survival [194, 195] . Multivariate analysis found MGMT gene to be an independent prognostic factor for survival found, representing the important role of epigenetic process in gallbladder carcinogenesis [195] . The recent report showed that promoter methylation of specific genes like CDH1, CDKN2A-p16, REPRIMO (tumor suppressor gene family) and UCHL1 (also known as PGP9.5) have important role in gallbladder carcinogenesis [196] . Other studies conducted on GBC have shown variable methylation pattern of a number of genes Table  7 [ 81, 82, 193208] . In addition, with the help of advanced technologies like high resolution allele stratification (allelotyping analysis) investigated very high frequencies of 3p (100%), 8p (100%), 9q (88%), 22q (92%) sites in gallbladder cancer that lead to positional identification of tumor suppressor genes associated with GBC malignancies and pathogenesis [57, 58, 109, 209] . Moreover, some wellknown tumor suppressor genes that [81, 194, 195, 198, 199] hMLH1 Human homologs of Mismatch repair 0%-14% Chile, United States [81, [193] [194] [195] 199 ] MutL gene of bacteria p16
Cyclin-dependent kinase Cell cycle regulation 15%-60% Chile, United States, Germany [81, 82, 195, [197] [198] [199] 201, 202] Microsatellite instability are present in chromosomes like 3p, 5q, 8p,13q and 18q can also influence the gallbladder cancer formation [57, 58, 109, 209] .
Candidate genes for gallbladder cancer susceptibility
The merely successful mechanism for identifying low or moderate penetrance cancer genes, is the analysis of genes involved in candidate loci. Therefore, these genes are also termed as candidate genes. The candidate gene analysis is done via casecontrol study, in which allele frequencies in cancer patients and healthy controls are compared and obtained results are analyzed statistically. Candidate modifier genes are selected on the basis of biological plausibility. Most studies are based on genes that encode proteins, thought to be involved in carcinogenesis, such as those involved in apoptosis, cellcycle control, DNA repair, xenobiotic metabolism, hormonal and inflammatory pathway or other risk factors. Moreover, known genes account for a small proportion of the heritability of gallbladder cancer, and it is likely that many genes with modest effects are yet to be found. A study by Wang et al [210] from china suggested about CCKinduced impaired gallbladder emptying in patients having gallstones. Most of the candidate genes identified so far are related to the classical rate limiting enzymes and proteins of lipid metabolism, steroidogenesis, lipid transport, bile acid synthesis, bile canalicular transport, gallbladder contractility, cell cycle, DNA repair and Inflammatory pathway [211233] . Till now there are very limited studies in GBC which are independently replicated which includes OGG1rs1052133, TP53rs1042522, GSTM1 null polymorphism and CYP1A1rs1048943 polymorphism [48] . No definitive conclusions can be drawn due to limited number of studies. Hence there is a great need to explore genes related to GBC susceptibility. Table 8 [30, 214273] shows an overview of candidate gene studies reported in GBC. The only one genomewide association study conducted in gallbladder cancer identified a SNP (rs7504990) in DCC gene which was associated with six times gallbladder cancer risk in the Japanese population. It has also been reported that reduced expression of DCC gene (deleted in colorectal cancer, 18q21.3) was designated to be associated with the greater aggressiveness of the disease which include increased proliferation, poorly differentiated histology, and metastasis through loss of adhesiveness [234] .
However genome wide association study (GWAS)
identified SNPs was replicated in Indian population and the study found no individual association of DCCrs7504990 but haplotype analysis of DCC gene found the cumulative effect of Grs2229080Ars4078288Crs7504990 Ars714 haplotypes in Gallbladder Cancer predisposition [235] .
Molecular pathogenesis of GBC
Gallbladder carcinoma develops through a serious of events before converting in to invasive malignancy. Any exposure to carcinogens may convert normal gallbladder epithelium to condition called metaplasia which subsequently forms dysplasia to carcinoma in situ (CIS), and finally proceeding to invasive carcinoma in about 15 years [274, 275] . The multistage pathogenesis of gallbladder carcinoma begins with gallstones giving rise to a condition called chronic cholecystitis, which increases to risk to gallbladder cancer formation. More than 90% of patients with gallbladder carcinoma show dysplasia and CIS [274, 275] . There is an unusual asymmetric thickening of the gallbladder wall with infiltration to surrounding structures in gallbladder cancer. Maximum cases reported in carcinomas of gallbladder are adenocarcinomas (80%95%). Adenocarconomas can further be of papillary, tubular, mucinous, or signet cell type. Some other types which are present in very low frequency include: squamous cell carcinoma (16%), undifferentiated or anaplastic carcinoma (2%7%), and adenosquamous carcinoma (1%4%) [276] . Most of GBCs (60%) are found in the fundus, near about 30% in the body, and 10% in the neck region.
Tumor markers in GBC
Till date there is no reliable tumor marker developed which can be employed in diagnosis of gallbladder cancer. The only two markers i.e., carcinoembryonic antigen (CEA) and carbohydrate antigen 199 are most often elevated in advanced stages with a low specificity. So most often they are not used in standalone diagnosis of GBC [277] . However, there are other tumor markers like CA125, CA199, CEA (carcino embryonic antigen), cancer antigens (CA) and CA242, which are for diagnosis of different other types of cancer (e.g., gastric, liver, pancreatic), have also been researched in diagnosis of gallbladder cancer but the obtained results are highly inconsistent [278280] . In addition some previous reports have shown CA [277, 281, 282] .
CONCLUSION
Various lines of evidence suggest role for various environmental risk factors in Gallbladder carcinoma. Despite of many articles regarding genetic pre disposition of gallbladder cancer there is no established genetic marker. Also, very limited Genome wide association studies (GWAS) have been conducted in gallbladder cancer till now. The evidencebased model of gallbladder carcino genesis and its dissemination by Barreto et al [283] serves as a basic platform for elucidation of molecular mechanisms involved in cancer development which based on recent data can be improved by discovery of other signature mutations using high throughput studies. Technological advancement can be helpful more understanding of pathogenic mechanisms underlying neoplastic conversion of gallbladder cancer muscosa. The tumor markers available for diagnosis GBC has also not of very high specificity and not discovered until advanced stage of the disease leading to complexity of the treatment. Exome sequencing of gallbladder cancer tissue has found ERBB pathway as most dysregulated pathway in this disease. Although the studies have been published in highly distinguished journals but they need to be validated before clinical implication. Moreover, limited studies with small sample size are not robust enough to conclude anything. Regardless of improvement in technologies in research field there is no accountable better ment in the prognosis of GBC patients. The future therefore should be engaged towards good quality research focused on early diagnosis and refinement of prognostic information to ultimately improve the management strategies of gallbladder cancer. Present review provides a comprehensive summery of the studies conducted regarding its Epidemiology, Pathogenesis and molecular genetics under a single umbrella. This will be helpful for the researchers to understand the current scenario of research work and how much success we have gained till now. Based on that future research work can be planned in appropriate directions. 
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